Cargando…
Extended Duration Vascular Endothelial Growth Factor Inhibition in the Eye: Failures, Successes, and Future Possibilities
Vascular endothelial growth factor (VEGF) plays a pivotal role in the development of neovascularization and edema from several common chorioretinal vascular conditions. The intravitreally injected drugs (aflibercept, bevacizumab, conbercept, pegaptanib, and ranibizumab) used to treat these condition...
Autor principal: | Stewart, Michael W. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5874834/ https://www.ncbi.nlm.nih.gov/pubmed/29382038 http://dx.doi.org/10.3390/pharmaceutics10010021 |
Ejemplares similares
-
Local acting Sticky-trap inhibits vascular endothelial growth factor dependent pathological angiogenesis in the eye
por: Michael, Iacovos P, et al.
Publicado: (2014) -
Long-Term Visual Outcomes for a Treat and Extend Anti-Vascular Endothelial Growth Factor Regimen in Eyes with Neovascular Age-Related Macular Degeneration
por: Mrejen, Sarah, et al.
Publicado: (2015) -
Vitreous levels of vascular endothelial growth factor in eyes with anterior hyaloidal fibrovascular proliferation
por: Kobayashi, Takaki, et al.
Publicado: (2010) -
Possible role of transforming growth factor-β1 and vascular
endothelial growth factor in Fabry disease nephropathy
por: LEE, MI HEE, et al.
Publicado: (2012) -
Vascular endothelial growth factors and vascular permeability
por: Bates, David O.
Publicado: (2010)